Follow
Andrew M. King
Andrew M. King
Empress Therapeutics
Verified email at empresstx.com
Title
Cited by
Cited by
Year
The comprehensive antibiotic resistance database
AG McArthur, N Waglechner, F Nizam, A Yan, MA Azad, AJ Baylay, ...
Antimicrobial agents and chemotherapy 57 (7), 3348-3357, 2013
18342013
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
AM King, SA Reid-Yu, W Wang, DT King, G De Pascale, NC Strynadka, ...
Nature 510 (7506), 503-506, 2014
5502014
Identifying producers of antibacterial compounds by screening for antibiotic resistance
MN Thaker, W Wang, P Spanogiannopoulos, N Waglechner, AM King, ...
Nature biotechnology 31 (10), 922-927, 2013
2372013
A pressure test to make 10 molecules in 90 days: external evaluation of methods to engineer biology
A Casini, FY Chang, R Eluere, AM King, EM Young, QM Dudley, A Karim, ...
Journal of the American Chemical Society 140 (12), 4302-4316, 2018
1462018
A common platform for antibiotic dereplication and adjuvant discovery
G Cox, A Sieron, AM King, G De Pascale, AC Pawlowski, K Koteva, ...
Cell chemical biology 24 (1), 98-109, 2017
1262017
Molecular mechanism of avibactam-mediated β-lactamase inhibition
DT King, AM King, SM Lal, GD Wright, NCJ Strynadka
ACS infectious diseases 1 (4), 175-184, 2015
1152015
Structural and kinetic characterization of diazabicyclooctanes as dual inhibitors of both serine-β-lactamases and penicillin-binding proteins
AM King, DT King, S French, E Brouillette, A Asli, JAN Alexander, ...
ACS chemical biology 11 (4), 864-868, 2016
652016
Total Synthesis and Activity of the Metallo‐β‐lactamase Inhibitor Aspergillomarasmine A
K Koteva, AM King, A Capretta, GD Wright
Angewandte Chemie International Edition 55 (6), 2210-2212, 2016
622016
Zinc Chelation by a Small-Molecule Adjuvant Potentiates Meropenem Activity in Vivo against NDM-1-Producing Klebsiella pneumoniae
SB Falconer, SA Reid-Yu, AM King, SS Gehrke, W Wang, JF Britten, ...
ACS infectious diseases 1 (11), 533-543, 2015
612015
Total synthesis of aspergillomarasmine A and related compounds: A sulfamidate approach enables exploration of structure–activity relationships
SA Albu, K Koteva, AM King, S Al‐Karmi, GD Wright, A Capretta
Angewandte Chemie 128 (42), 13453-13456, 2016
472016
A molecular portrait of maternal sepsis from Byzantine Troy
AM Devault, TD Mortimer, A Kitchen, H Kiesewetter, JM Enk, GB Golding, ...
Elife 6, e20983, 2017
392017
Selection for constrained peptides that bind to a single target protein
AM King, DA Anderson, E Glassey, TH Segall-Shapiro, Z Zhang, ...
Nature Communications 12 (1), 6343, 2021
162021
Characterizing chemical signaling between engineered “microbial sentinels” in porous microplates
CA Vaiana, H Kim, J Cottet, K Oai, Z Ge, K Conforti, AM King, AJ Meyer, ...
Molecular Systems Biology 18 (3), e10785, 2022
72022
Functional expression of diverse post-translational peptide-modifying enzymes in Escherichia coli under uniform expression and purification conditions
E Glassey, AM King, DA Anderson, Z Zhang, CA Voigt
Plos one 17 (9), e0266488, 2022
52022
Discovery and characterization of novel beta-lactamase inhibitors
AM King
42016
Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra
AM King, Z Zhang, E Glassey, P Siuti, J Clardy, CA Voigt
Nature Microbiology 8 (12), 2420-2434, 2023
32023
Split intein-based selection for peptide binders
CA Voigt, A King, E Glassey
US Patent App. 18/009,357, 2023
2023
INHIBITORS OF METALLO-ß-LACTAMASE-ENZYMES
G Wright, W Wang, A King
US Patent App. 16/014,167, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–18